Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: BioBait who wrote (3383)	10/5/2021 5:22:30 PM
From: CuttingEdge Bio	1 Recommendation Recommended By pheilman_ Read Replies (2) \| Respond to of 3557

Not sure if you're aware, but they already got a new re-order, announced less than a month ago. 1.4m doses which are being provided mostly in 4th quarter and the rest of the order by Jan 31 2022. I don't know about you, but no matter how convenient a pill is, the efficacy of the pill isn't as good, and I'd rather take antibodies than a mutagen anyway. Why would I care about potentially taking 4 shots? It's a one-time deal. Covid doesn't reinfect very often. Many states now have at-home infusion programs too. There will be demand for this treatment so long as Covid still exists. Maybe it won't be bringing in 3billion per year anymore as it did for the first 2 years of pandemic, but that would be pretty unrealistic to expect wouldn't it? The vaccines clearly left plenty of residual risk in the elderly and forcing entire population to get shots every 6 months is not a sustainable approach. What is the "whole infectious program" in particular of Regeneron's that was hurt by this pill? I don't buy into any of these narratives, personally. The stock goes down, everyone sad and scared. The stock goes up, everyone rejoicing. This gets old.